Infectious Diseases

The Division of Infectious Diseases provides consultation in the diagnosis and management of infectious diseases in children – especially recurrent, rare, or difficult to treat infections, including HIV/AIDS.

Consultative services are provided for children with:

Physicians also conduct follow-up for children admitted to Children's Hospital for infections. In addition, they assist in the laboratory diagnosis of infections and in the selection of therapeutic and preventive strategies including antimicrobials, vaccines, and immunoglobulins. Consultation is available for international travelers.

Learn more about Infectious Diseases research at Children's Hospital.

Learn how to stay safe from ticks (provided by WPXI-TV).

Referral Requirements

Referrals are required from primary care physicians or other Children’s Hospital specialty services. Referrals for patients enrolled in managed care insurance plans also may require authorization from the insurance provider and primary care physician. We strongly recommend that you consult with your primary physician to ensure that a visit to the Infectious Disease clinic will be beneficial for your child. In addition, notes and lab results should be sent from your primary physician’s office to our clinic before the visit so we can provide the best care for your child. All necessary referral and authorization forms must be received before the patient’s visit. For accurate provider numbers or more information, please call the office number listed.



Clinical Trials

John Williams, MD

Read more

Brian Campfield, MD

Read more

Michael Green, MD, MPH

Read more

Philana Lin, MD

Read more

Marian Michaels, MD, MPH

Read more

Andrew Nowalk, MD, PhD

Read more
  • Infectious Diseases

    Children's Hospital of Pittsburgh of UPMC
    4401 Penn Avenue
    Floor 3
    Pittsburgh PA, 15224

  • Acute Rheumatic Fever Study

    Acute Rheumatic Fever in Allegheny County: Incidence and GABHS M-Types Read more

    Candidiasis Treatment with Anidulafungin

    A Study to Assess the Pharmacokinetics, Safety and Efficacy of Anidulafungin When Used to Treat Children with Invasive Candidiasis, Including Candidemia Read more

    Candidiasis Treatment with Micafungin in Neonates – Phase III

    A Study to Compare the Efficacy and Safety of Micafungin Versus Amphotericin B Deoxycholate for the Treatment of Neonatal Candidiasis Read more

    Clostridium Difficile-Associated Diarrhea Treatment with Fidaxomicin – Phase IIa

    Study to Determine the Safety, Tolerability and Pharmacokinetics of Fidaxomicin Oral Suspension or Tablets in Pediatric Subjects with Clostridium Difficile-associated Diarrhea (CDAD) Read more

    Influenza Treatment in Immunocompromised Patients – Phase IV

    Treatment of Immunocompromised Patients with Conventional and High Dose Oseltamivir Read more

    Influenza Treatment with Zanamivir for Hospitalized Patients

    Study to Evaluate the Safety and Tolerability of Intravenous Zanamivir in the Treatment of Hospitalized Adult, Adolescent and Pediatric Subjects with Confirmed Influenza Infection Read more

    MRSA Decolonization Study

    Read more

    Respiratory Fungal Infection Treatment with Voriconazole – Phase II

    Voriconazole as Therapy for Treatment of Invasive Aspergillosis and Molds Read more

    Skin Infection Treatment with Ceftaroline – Phase II

    A Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetics of Ceftaroline Versus Comparator in Pediatric Subjects With Acute Bacterial Skin and Skin Structure Infections Read more

    Urinary Tract Infection Treatment with Doripenem

    A Safety and Tolerability Study of Doripenem Compared With Cefepime in Hospitalized Children With Complicated Urinary Tract Infections Read more